Search Results
CK-1827452 10mg 10mg | Purity Not Available
Adooq Bioscience
LDN193189 50mg 50mg | Purity Not Available
Adooq Bioscience
LDN193189 is a highly potent small molecule BMP inhibitor that inhibits BMP type I receptors ALK2 (IC50: 5 nM), ALK3 (IC50: 30 nM) and ALK6 (TGF??1/BMP signaling) and subsequent SMAD phosphorylation.
More Information Supplier PagePP121 25mg 25mg | Purity Not Available
Adooq Bioscience
PP121 is a dual inhibitor of receptor tyrosine kinases (RTKs) (IC50 < 0.02 ??M for Abl, Src, VEGFR-2 and PDGFR) and PI 3-K family kinases (IC50 < 0.06 ??M for p110??, DNA-PK and mTOR).
More Information Supplier PagePP121 50mg 50mg | Purity Not Available
Adooq Bioscience
PP121 is a dual inhibitor of receptor tyrosine kinases (RTKs) (IC50 < 0.02 ??M for Abl, Src, VEGFR-2 and PDGFR) and PI 3-K family kinases (IC50 < 0.06 ??M for p110??, DNA-PK and mTOR).
More Information Supplier PageBMS 599626 50mg 50mg | Purity Not Available
Adooq Bioscience
BMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMS 599626 5mg 5mg | Purity Not Available
Adooq Bioscience
BMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMS 599626 (AC480) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
BMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMS 599626 100mg 100mg | Purity Not Available
Adooq Bioscience
BMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMS 599626 10mg 10mg | Purity Not Available
Adooq Bioscience
BMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier Page